[Clinical benefit of antiestrogens for breast cancer].

Tamoxifen has significantly improved mortality of both pre- and postmenopausal women with hormone receptor-positive breast cancer. Recent clinical trials have demonstrated benefits of aromatase inhibitor therapy in adjuvant regimens for postmenopausal women. Tamoxifen is now expected to demonstrate potential benefits for bone health during endocrine… CONTINUE READING